d2 receptor

Published research on d2 receptor.

AddictionJun 17, 2026

Chronic Stress Increased Mouse D1 and D2 Dopamine Receptors

Chronic stress is a candidate mechanism for both depression and addiction risk. A 2026 mouse study found that 28 days of unpredictable chronic mild stress increased striatal dopamine D1 rece…

Read article →

DrugsMay 3, 2026

Lurasidone Improves Positive Symptoms of Schizophrenia More Than Negative

Lurasidone is approved for schizophrenia and bipolar depression on the strength of acute trials that mostly reported a single number: the change in PANSS total score. A 2026 post-hoc analysi…

Read article →

DrugsJan 20, 2024

Proton Pump Inhibitors (PPIs) May Treat OCD via Neuronal pH & Dopamine Modulation (2024 Study)

Obsessive-compulsive disorder (OCD), a prevalent neuropsychiatric condition, presents significant treatment challenges due to its varied symptom patterns and poor response to traditional med…

Read article →

DrugsApr 14, 2016

Reglan (Metoclopramide) For Migraines: An Emergency Abortive Therapy

Reglan (Metoclopramide) is a medication approved by the FDA for the treatment of gastroparesis or delayed stomach emptying. Gastroparesis often occurs as a result of conditions such as GERD …

Read article →

DrugsSep 22, 2015

Vraylar (Cariprazine) Approved For Schizophrenia & Bipolar Disorder

Vraylar (Cariprazine) was approved by the FDA on September 17, 2015 for the treatment of schizophrenia and mania associated with bipolar disorder. In clinical trials, the drug was referenced…

Read article →